Home » Topics » Regulatory

Regulatory
RSS

Tolmetin eyedrop formulation evaluated in rabbits

Sep. 9, 1997

Pharmacia & Upjohn's urinary incontinence treatment approved in Sweden

Sep. 9, 1997

RTP licenses improved propofol formulation to AMRAD

Sep. 5, 1997

Novartis migraine treatment nears U.S. approval

Sep. 5, 1997

Merck's asthma treatment receives first approvals

Sep. 4, 1997

First approval for Zeneca's Seroquel

Sep. 3, 1997

Ranitidine shows no benefit in psoriasis

Sep. 2, 1997

Migraine prophylaxis with bisoprolol

Sep. 1, 1997

Famotidine for schizophrenia

Sep. 1, 1997

FDA clears new formulation of Imitrex

Sep. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...